Zuzana Tóthová
- Aging top 0.2%
- Hematology top 1%
- Acute Myeloid Leukemia Research 10
- Molecular Biology top 0.5%
- FOXO transcription factor regulation 9
- Genomics and Chromatin Dynamics 6
- RNA Research and Splicing 6
- CRISPR and Genetic Engineering 5
- Epigenetics and DNA Methylation 5
- PI3K/AKT/mTOR signaling in cancer 4
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Co-authors
- David E. RootJohn G. DoenchMudra HegdeIan C. P. SmithMeagan E. SullenderJennifer ListgartenKatherine DonovanNicolò Fusi
- Partner nations
- United StatesSlovakiaUnited Kingdom
In The Last Decade
Zuzana Tóthová
46 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Aging 709
- Hematology 1.1k
- Business and International Management 186
- Molecular Biology 6.5k
- Genetics 554
Countries citing papers authored by Zuzana Tóthová
This map shows the geographic impact of Zuzana Tóthová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuzana Tóthová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuzana Tóthová more than expected).
Fields of papers citing papers by Zuzana Tóthová
This network shows the impact of papers produced by Zuzana Tóthová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuzana Tóthová. The network helps show where Zuzana Tóthová may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zuzana Tóthová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 17 | |
| 4 | 2024 | 8 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 19 | |
| 7 | 2021 | 26 | |
| 8 | 2021 | 26 | |
| 9 | 2021 | 62 | |
| 10 | 2021 | 35 | |
| 11 | 2017 | 2 | |
| 12 | 2016 | 189 | |
| 13 | 2016 | 195 | |
| 14 | Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9breakdown → | 2016 | 2646 |
| 15 | Akt/foxo signaling pathway enforces the differentiation blockade in myeloid leukemias | 2011 | 1 |
| 16 | 2011 | 217 | |
| 17 | 2010 | 157 | |
| 18 | FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasisbreakdown → | 2007 | 859 |
| 19 | The Retinoblastoma Binding Protein RBP2 Is an H3K4 Demethylasebreakdown → | 2007 | 336 |
| 20 | FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stressbreakdown → | 2007 | 1223 |
About Zuzana Tóthová
Zuzana Tóthová is a scholar working on Hematology, Aging and Genetics, having authored 47 papers that have together received 8.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), FOXO transcription factor regulation (9 papers), Genomics and Chromatin Dynamics (6 papers), RNA Research and Splicing (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), CRISPR and Genetic Engineering (5 papers), Epigenetics and DNA Methylation (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Aging (709 citations), Hematology (1.1k citations) and Business and International Management (186 citations). Zuzana Tóthová has collaborated with scholars based in United States, Slovakia and United Kingdom. Frequent co-authors include David E. Root, John G. Doench, Mudra Hegde, Ian C. P. Smith, Meagan E. Sullender, Jennifer Listgarten, Katherine Donovan, Nicolò Fusi, Craig B. Wilen and Robert C. Orchard. Their work appears in journals such as Blood, Cell, Cell stem cell, International Journal of Molecular Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.